BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2837363)

  • 1. New approaches to animal vaccines utilizing genetic engineering.
    Devaney MA
    Crit Rev Microbiol; 1988; 15(3):269-95. PubMed ID: 2837363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marker vaccines and the impact of their use on diagnosis and prophylactic measures.
    Vannie P; Capua I; Le Potier MF; Mackay DK; Muylkens B; Parida S; Paton DJ; Thiry E
    Rev Sci Tech; 2007 Aug; 26(2):351-72. PubMed ID: 17892157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of virus infection-associated antigen and 3D antibodies in cattle vaccinated against foot and mouth disease.
    O'Donnell VK; Smitsaart E; Cetra B; Duffy S; Finelli J; Boyle D; Draghi G; Fondevila N; Schudel AA
    Rev Sci Tech; 1997 Dec; 16(3):833-40. PubMed ID: 9567309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines.
    Morgan DO; Moore DM
    Am J Vet Res; 1990 Jan; 51(1):40-5. PubMed ID: 2154148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Veterinary vaccines for animal and public health.
    Pastoret PP; Jones P
    Dev Biol (Basel); 2004; 119():15-29. PubMed ID: 15742615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The opinion of the production sector on the role of vaccines in the control and eradication of livestock diseases in Argentina.
    Miguens L
    Rev Sci Tech; 2007 Aug; 26(2):479-83, 485-8. PubMed ID: 17892168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards the development of a new foot and mouth disease vaccine.
    Winther MD
    Dev Biol Stand; 1985; 59():73-7. PubMed ID: 2989048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between 146S antigen dosage and antibody titers after foot-and-mouth disease vaccination in cattle and swine].
    Liebermann HT; Thalmann G; Nöckler A; Felfe P
    Arch Exp Veterinarmed; 1988 Jul; 42(4):528-36. PubMed ID: 2847677
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of vaccination against foot-and-mouth disease on results of the immunodiffusion test for the demonstration of precipitating bovine leukosis virus antibodies].
    Straub OC
    Dtsch Tierarztl Wochenschr; 1983 Apr; 90(4):135-7. PubMed ID: 6305624
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined vaccination of cattle against FMD and rabies.
    Palanisamy R; Ramanna BC; Ananda Rao K; Srinivasan VA
    Microbiologica; 1992 Jan; 15(1):45-9. PubMed ID: 1313530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunologic relations between the foot-and-mouth disease virus isolates A5 Westerwald 1951 and A5 Bernbeuren 1984].
    Bengelsdorff HJ
    Berl Munch Tierarztl Wochenschr; 1987 Aug; 100(8):264-8. PubMed ID: 2820373
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immune response against foot-and-mouth disease virus in cattle: effect of vaccination].
    Braun M; Sigal L; Mundo S; Ramayo L; Jar AM; Gómez G; Fontanals A; Mazzuca GO
    Medicina (B Aires); 1989; 49(3):216-20. PubMed ID: 2562135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of neutralizing antibodies in calves after single vaccination against foot-and-mouth disease virus type ASIA 1 in the field].
    Dimitriadis I; Chondrokouki E
    Berl Munch Tierarztl Wochenschr; 1991 Sep; 104(9):313-6. PubMed ID: 1659374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current status of immunoprophylaxis against foot-and-mouth disease].
    Benndorf E; Thalmann G
    Arch Exp Veterinarmed; 1978; 32(3):326-36. PubMed ID: 211978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Foot-and-mouth disease in buffaloes (Bubalus bubalis, Linnaeus, 1758): search of antiantigen antibodies and isolation of the virus].
    Jerez JA; Pinto AA; Arruda NV; Koseki I; Abuhab TG; Rodrigues MA
    Arq Inst Biol (Sao Paulo); 1979; 46(3-4):111-5. PubMed ID: 233417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunogenic properties of foot-and-mouth vaccines].
    Tekerlekov P; Nikolova E; Dilovski M
    Vet Med Nauki; 1983; 20(5-6):46-51. PubMed ID: 6318424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The place of marker vaccines in control and eradication of animal diseases--aspects of comparative interest.
    Pastoret PP
    Dev Biol (Basel); 2005; 121():181-8. PubMed ID: 15962481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response evaluation of a genetically engineered foot-and-mouth disease virus polypeptide immunogen in cattle.
    McKercher PD; Moore DM; Morgan DO; Robertson BH; Callis JJ; Kleid DG; Shire SJ; Yansura DG; Dowbenko D; Small B
    Am J Vet Res; 1985 Mar; 46(3):587-90. PubMed ID: 2986495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and opportunities in developing and marketing vaccines for OIE List A and emerging animal diseases.
    Gay CG; Salt J; Balaski C
    Dev Biol (Basel); 2003; 114():243-50. PubMed ID: 14677694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.